Circulating thyrotropin receptor messenger ribonucleic acid is not an effective marker in the follow-up of differentiated thyroid carcinoma

BACKGROUND: Circulating thyrotropin receptor messenger ribonucleic acid (TSHR mRNA) assay has been validated in the follow-up of differentiated thyroid carcinoma (DTC) because of its high sensitivity during thyroid hormone therapy and no interference with endogenous anti-thyroglobulin antibodies (Tg...

Descripción completa

Detalles Bibliográficos
Autores principales: Ausavarat, Surasawadee, Sriprapaporn, Jiraporn, Satayaban, Busara, Thongnoppakhun, Wanna, Laipiriyakun, Aunchalee, Amornkitticharoen, Boontham, Chanachai, Rujaporn, Pattanachak, Chaveevan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523908/
https://www.ncbi.nlm.nih.gov/pubmed/26244057
http://dx.doi.org/10.1186/s13044-015-0024-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523908/
https://www.ncbi.nlm.nih.gov/pubmed/26244057
http://dx.doi.org/10.1186/s13044-015-0024-4

Ejemplares similares